Stocks
Novo Nordisk A S NVO
- Close
- $38.31
- 09/29 close
- Day change
- −1.0%
- vs previous close
- Volume
- 857,908
- −14.3% vs 30-day average
- 52-week range
- $35.13$64.13
- 1-year return
- −31.0%
- vs the close a year ago
Company
- Exchange
- NYSE
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bagsvaerd Denmark
- Fiscal year end
- 12/31
Members of Congress reported 4 trades in Novo Nordisk A S NVO in the past 90 days (2 purchases, 2 sales).
- Next earnings
- No record
- Estimated from the last four quarters
Price
$38.31Day −1.0%1 year −31.0%
26-week trading
Common questions
- Which members of Congress traded Novo Nordisk A S NVO recently?
- The latest reported trades: Rep. Kevin Hern, full sale on 09/10 (reported 09/25), Rep. Kevin Hern, partial sale on 08/31 (reported 09/25), Rep. Scott Franklin, purchase on 08/26 (reported 09/17), Sen. Alan Armstrong, purchase on 03/30 (reported 07/21) and Sen. Tommy Tuberville, full sale on 24/01/19 (reported 24/02/14).